2nd Antimicrobial Chemotherapy Conference

21 January 2020
London, England

Join us at the World Health Summit to learn how GARDP’s ‘5 BY 25’ goal will accelerate the development and delivery of five new and improved treatments to address antibiotic-resistant
infections that pose the greatest threat to health and development.

GARDP and FIND part of ARC Research Hub on AMR

[Geneva – 19 August 2019] 

GARDP and FIND welcome the Australian Minister for Education’s announcement of $5m to establish an Australian Research Council (ARC) Research Hub to Combat Antimicrobial Resistance, which will be led by the Kirby Institute.

Uniting against antibiotic resistance: 5 BY 25

28 October 2019
Berlin, Germany

Join us at the World Health Summit to learn how GARDP’s ‘5 BY 25’ goal will accelerate the development and delivery of five new and improved treatments to address antibiotic-resistant
infections that pose the greatest threat to health and development.

GARDP announces ‘5 BY 25’ goal in response to the growing burden of antibiotic resistant infections

[Geneva – 26 June 2019] 

GARDP calls upon the global community to work with it to develop and deliver 5 new treatments by 2025 to address the most urgent public health needs

Today GARDP announces its ‘5 BY 25’ goal to deliver five new treatments in response to the growing global threat of antimicrobial resistance (AMR). GARDP’s five treatments will focus on the priority bacterial pathogens identified by the World Health Organization (WHO).

2019 ASM/ESCMID Conference on Drug Development

3 September 2019
Boston, USA

Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR.

The 6th Nikkei Asia Africa Conference on Communicable Diseases 2019

31 August 2019
Kanagawa, Japan

Nikkei Inc. has been organizing the annual Nikkei Asian Conference on Communicable Diseases since 2014, gathering internationally renowned experts in the field, both within and outside Japan, representatives of the private sector, and high-ranking government officials responsible for health.

ASM Microbe 2019

20 June 2019
San Francisco, USA

Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session, drug discovery efforts originating from academic laboratories will be discussed.